Benz; Christopher C.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Benz; Christopher C..The latest application filed is for "inhibition of proline catabolism for the treatment of cancer and other therapeutic applications".

Company Profile

0.7.8

Benz; Christopher C. - Novato CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Inhibition of proline catabolism for the treatment of cancer and other therapeutic applications Grant 10,517,844 - Scott , et al. Dec	2019-12-31
Inhibition Of Proline Catabolism For The Treatment Of Cancer And Other Therapeutic Applications App 20170348266 - SCOTT; GARY K. ; et al.	2017-12-07
Impairment Of The Large Ribosomal Subunit Protein Rpl24 By Depletion Or Acetylation App 20150359794 - Benz; Christopher C. ; et al.	2015-12-17
Screening System For Modulators Of Her2 Mediated Transcription And Her2 Modulators Identifed Thereby App 20120264159 - Benz; Christopher C.	2012-10-18
Immunoliposomes that optimize internationalization into target cells Grant 7,871,620 - Benz , et al. January 18, 2	2011-01-18
Immunoliposomes that Optimize Internationalization into Target Cells App 20100068255 - Benz; Christopher C. ; et al.	2010-03-18
Immunoliposomes that optimize internationalization into target cells Grant 7,507,407 - Benz , et al. March 24, 2	2009-03-24
Immunoliposomes that optimize internationalization into target cells App 20070031484 - Benz; Christopher C. ; et al.	2007-02-08
Immunoliposomes that optimize internalization into target cells Grant 7,135,177 - Benz , et al. November 14, 2	2006-11-14
ETS-related gene overexpressed in human breast and epithelial cancers Grant 7,125,969 - Benz , et al. October 24, 2	2006-10-24
Novel pathways in the etiology of cancer App 20060024691 - Benz; Christopher C.	2006-02-02
Screening system for modulators of her2 mediated transcription and her2 modulators identified thereby App 20050123896 - Benz, Christopher C.	2005-06-09
Immunoliposomes that optimize internalization into target cells App 20010016196 - Benz, Christopher C. ; et al.	2001-08-23
Immunoliposomes that optimize internalization into target cells Grant 6,214,388 - Benz , et al. April 10, 2	2001-04-10
Method of determining functional estrogen receptors for prognosis of cancer Grant 5,292,638 - Benz , et al. March 8, 1	1994-03-08

Company Registrations

NCAGE Code	4VER5	BENZ, CHRISTOPHER C
CAGE Code	4VER5	BENZ, CHRISTOPHER C
DUNS	806899394	BENZ, CHRISTOPHER C

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.